Vacuum Plasma Surface Modification of 3Y-TZP Zirconia Implants
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Dental 3Y-TZP zirconia implants face challenges in achieving improved chemical activity, cell adhesion, and antibacterial effects, which are essential for long-term functionality and biocompatibility.
Innovation Solution
The surface of 3Y-TZP zirconia materials and implants is modified using plasma treatment under vacuum conditions, specifically with a carrier gas mixture of N2 or N2/Ar, to enhance cell proliferation, adhesion, motility, and antibacterial properties.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional zirconia implants are used, then manufacturing simplicity is maintained, but cell adhesion and antibacterial effects are insufficient
Solution Approach 1:
The patent applies plasma treatment under vacuum conditions with specific gas compositions (N2, N2/Ar mixtures) to modify the surface properties of zirconia implants. By controlling plasma parameters such as gas type, pressure, and treatment duration, the surface chemistry and topography are altered to enhance cell adhesion and antibacterial effects without changing the bulk material composition
Solution Approach 2:
The patent utilizes vacuum plasma treatment in an inert or controlled atmosphere to modify the zirconia surface. The vacuum environment prevents unwanted oxidation and allows precise control over plasma-generated reactive species that interact with the surface, creating a controlled modification process that enhances biocompatibility
2Reliability
If conventional zirconia implants are used, then manufacturing simplicity is maintained, but antibacterial effects are insufficient
Solution Approach 1:
The patent employs plasma treatment with specific gas compositions (N2, N2/Ar) and controlled vacuum conditions to alter the surface properties of zirconia implants. By adjusting plasma parameters, the surface is modified to exhibit enhanced antibacterial properties through increased chemical reactivity and modified surface energy, without affecting the bulk material
Solution Approach 2:
The patent replaces conventional mechanical surface treatment methods with plasma-based chemical modification. Instead of mechanical abrasion or coating, the invention uses plasma-generated reactive species to chemically modify the surface, achieving antibacterial effects through surface chemistry rather than physical structure
3Reliability
If plasma treatment is applied to enhance surface properties, then cell adhesion and antibacterial effects are improved, but treatment time and energy consumption increase
Solution Approach 1:
The patent optimizes plasma treatment parameters including gas composition (N2, N2/Ar ratios), vacuum pressure levels, and plasma power to achieve effective surface modification in minimal time. By carefully controlling these parameters, the treatment achieves the desired chemical reactivity and surface properties without excessive treatment duration
Solution Approach 2:
The patent determines optimal treatment durations that provide sufficient surface modification without excessive treatment time. Through systematic investigation of treatment time effects, the invention identifies the minimum effective treatment duration that achieves the desired biological properties, avoiding both under-treatment and over-treatment
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The plasma-treated zirconia surfaces exhibit improved cell adhesion, antibacterial effects, and chemical reactivity, reducing inflammatory reactions and enhancing the success rate of implant surgery.
Implementation Method 1
The surface of 3Y-TZP zirconia materials and implants is modified using plasma treatment under vacuum conditions
Data Source
AI summary
The present invention relates to a dental 3Y-TZP zirconia material whose surface is modified by plasma treatment, an implant and a manufacturing method thereof. The 3Y-TZP zirconia material and implant manufactured according to the present invention have improved cell adhesion and antibacterial effects, thereby improving biocompatibility and minimizing inflammatory reactions of the user.


